Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

First human trial for transgenic product

Sep. 13, 1996

Genetics Institute's recombinant factor IX submitted for approval

Sep. 6, 1996

Monoclonal antibody for thrombotic disorders from Teijin

Sep. 6, 1996

Roche and Genentech prepare prodrugs of fibrinogen antagonist

Sep. 6, 1996

Bayer's new cGMP PDE inhibitors

Sep. 6, 1996

Hisamitsu describes platelet aggregation inhibitors

Sep. 6, 1996

Antiplatelet agents described by Kissei

Aug. 30, 1996

TxA2/PGH2 antagonists described by Terumo

Aug. 30, 1996

Fibrinogen antagonists claimed by Thomae

Aug. 30, 1996

Fibrinogen antagonists from Nippon Steel

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...